EDITAS MEDICINE, INC. Payments of Stock Issuance Costs
EDITAS MEDICINE, INC. (EDIT) reported Payments of Stock Issuance Costs of $300.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2023-02-22
- EDITAS MEDICINE, INC. payments of stock issuance costs for the quarter ending 2019-09-30 was $100.00K.
- EDITAS MEDICINE, INC. payments of stock issuance costs for fiscal 2021 was $300.00K, a 0.00% change from fiscal 2020.
- EDITAS MEDICINE, INC. payments of stock issuance costs for fiscal 2020 was $300.00K.
- EDITAS MEDICINE, INC. payments of stock issuance costs for fiscal 2015 was $1.75M.
| Period end | Payments of Stock Issuance Costs 3 month | Payments of Stock Issuance Costs 12 month | Payments of Stock Issuance Costs 12 month as first filed |
|---|---|---|---|
| 2021-12-31 | $300.00K 10-K · filed 2023-02-22 | ||
| 2020-12-31 | $300.00K 10-K · filed 2023-02-22 | $100.00K 10-K · filed 2021-02-26 | |
| 2019-09-30 | $100.00K 10-Q · filed 2020-11-06 | ||
| 2015-12-31 | $1.75M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |